Status:
UNKNOWN
Self-help Lifestyle Medicine for Generalized Anxiety Symptoms
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Generalised Anxiety Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will examine the effects of smartphone-based lifestyle medicine for alleviating generalised anxiety symptoms in Chinese population. Since a range of lifestyle factors are involved in the pa...
Eligibility Criteria
Inclusion
- Hong Kong residents
- Aged ≥ 18 years
- Have a Generalized Anxiety Disorder-7 (GAD-7) score ≥ 8
- Able to read Chinese and type in Chinese or English
- Have an Internet-enabled mobile device (iOS or Android operating system)
- Willing to provide informed consent and comply with the trial protocol
Exclusion
- Current involvement in psychotherapy or recent changes in medication for anxiety
- A Patient Health Questionnaire-9 (PHQ-9) item 9 score \> 2, indicating a serious level of suicidal risk (referral information to professional mental health services will be provided)
- Self-disclosure of having unsafe health conditions for which physical activity or a change in diet was contraindicated by physicians
- Self-disclosure of a diagnosis of any major psychiatric, medical or neurocognitive disorders that make participation unsuitable or that may interfere with the adherence to the lifestyle modifications
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05278455
Start Date
June 1 2022
End Date
September 1 2023
Last Update
March 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Shatin, Hong Kong